We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 43

Janssen-Ortho v. Apotex, recusal by the judge, levofloxacin, June 14, 2010; motion to dismiss granted, levofloxacin, June 29, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

In a PMNOC case, Justice Shore granted an order of prohibition against Apotex in respect of its levofloxacin until patent expiry

Pfizer v Ratiopharm, appeal of decision on invalidity, Amlodipine Besylate, July 29, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 26 2010

In the Federal Court, Pfizer's patent for amlodipine besylate was held invalid on numerous grounds, including obviousness

Merck-Frosst-Schering Pharma GP v. Canada (Health) (2010 FC 933)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Merck-Frosst (“Merck”) applied for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for its generic version of Ezetimibe

Epicept Corporation v. Canada (Health) (2010 FC 956)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

The Minister of Health refused to grant data exclusivity to data from Epicept’s phase I and phase II clinical trials because CEPLENE is not an “innovative drug”

Apotex Inc. v. Shire Canada Inc. (2010 FC 1001)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Shire appealed the Order of Prothonotary Tabib denying it permission to amend, in part, its Statement of Defence

Novopharm v Pfizer, motion for interim relief pending appeal, pregabalin, October 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

See the earlier decisions in this case in the May 2010 and July 2010 editions of this newsletter

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Merck v Apotex, PMNOC proceedings, dorzolamide and timolol, October 22, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

Merck’s patent in this case (the ‘965 patent) covered the co-administration and co-formulation of dorzolamide and timolol (which was sold as COSOPT

Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary

Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine